Advaxis Cancer Immunotherapy Featured on CNN

[at noodls] – PRINCETON, N.J., March 3, 2014 (GLOBE NEWSWIRE) — Advaxis, Inc. (Nasdaq:ADXS), a biotechnology company developing the next generation of cancer immunotherapies, announced that ADXS-cHER2, its proprietary … more

View todays social media effects on ADXS

View the latest stocks trending across Twitter. Click to view dashboard

See who Advaxis is hiring next, click here to view